Prednisolone Acetate + OfloxacinThird Party Manufacturing in India

Prednisolone Acetate + Ofloxacin works via a dual-action pathway to eliminate bacterial infections while controlling the ocular inflammatory response. Prednisolone Acetate stops the synthesis of arachidonic acid derivatives by inhibiting phospholipase A2, reducing swelling, redness, and tissue scarring risks. Simultaneously, Ofloxacin acts as a broad-spectrum fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV enzymes. This block prevents bacterial DNA replication and transcription, leading to rapid bacterial cell death. Unlike standalone antibiotic drops, this combination speeds up patient recovery by managing both the infection and painful inflammation at the same time. It is highly effective and well-tolerated.

Therapeutic Uses

• Infectious Conjunctivitis: Treats superficial ocular infections caused by susceptible bacteria where significant inflammation is present.
• Post-Operative Prophylaxis: Prevents bacterial infections and controls inflammation following cataract or vitreoretinal surgeries.
• Corneal Injury Management: Protects healing corneal tissues from secondary infections while reducing inflammatory scarring.

Why Manufacturers Choose Prednisolone Acetate + Ofloxacin

The combination of a potent steroid with a reliable fluoroquinolone is highly favored by ophthalmologists for post-surgical care. Our partner production facilities utilize advanced aseptic filling systems and micro-suspension technologies that meet strict WHO-GMP criteria. Choosing Celesta for your Prednisolone Acetate + Ofloxacin third party manufacturing in India ensures a stable, high-performance product that aligns with verified chemical standards for CAS number 52-21-1 and related active components.